We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Ketone-Supressing Drug Combats Rare Brain Cancer in Mice

News   Aug 19, 2020 | Original story from the National Institutes of Health

 
Ketone-Supressing Drug Combats Rare Brain Cancer in Mice

Brains scans helped researchers discover that manipulating cancer cell metabolism may combat DIPGs and other brain tumors. Above is a scan of a DIPG patient. The study mentioned here was conducted in mice. Credit: Venneti lab, University of Michigan Medical School

 
 
Advertisement
 

RELATED ARTICLES

How the Loss of a Single Protein Leads to a Relentless Neuromuscular Disease

News

A new study has laid out the steps that connect the neuromuscular disorder spinal muscular atrophy (SMA) to the mutations in the gene SMN1 that cause the condition. The research may explain how the mutations affect motor neurons and points the way to a better understanding of SMA.

READ MORE

KRAS Inhibitor Sotorasib Achieves Durable Clinical Benefit in Early Trial

News

In a Phase I clinical trial for patients with advanced solid cancers marked by KRAS G12C mutations, the KRASG12C inhibitor sotorasib (AMG 510) resulted in manageable toxicities and durable clinical benefit.

READ MORE

Mapping Decision-Making in the Brain

News

Every day, we make hundreds of decisions. Decisions like these are shaped by our own values and preferences but understanding how our brains make these choices is still not well understood. Now, a new study has identified a new area of the brain that could be involved in cost-benefit decision-making.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE